The pattern of female genital hormonal disease in juvenile myoclonic epilepsy
https://doi.org/10.14412/2074-2711-2016-1S-24-30
Abstract
Patients and methods. The concentrations of sex steroid and tropic hormones were analyzed in 48 women of childbearing age who suffered from JME and received monotherapy or bitherapy with antiepileptic drugs (AEDs) for more than a year. For comparison of their values, a control group included 15 healthy women who did not take AEDs.
Results and discussion. 66.7% of the patients were found to have ovarian hormonal dysfunction characterized by a significant increase in the level of luteinizing hormone and testosterone in the follicular phase of the cycle and a decrease in that of progesterone in the luteal phase compared with the control group. The hormonal deviations were influenced by disease duration and age-related onset in JME. Generalized tonicclonic seizures concurrent with myoclonic ones, bitherapy, and disease onset before menarche and in the period of the menstrual cycle favored the development of hormonal deviations to a greater extent than myoclonic seizures only, monotherapy, and disease onset after the establishment of the cycle. Valproates were most commonly used in the therapy of JME; however, there were no significant differences in the hormonal deficiencies when different chemical groups of AEDs were administered.
About the Authors
D. V. AnisimovaRussian Federation
Department of Neurology with Course of Neurosurgery and Medical Genetics
R. V. Magzhanov
Russian Federation
Department of Neurology with Course of Neurosurgery and Medical Genetics
P. N. Vlasov
Russian Federation
Department of Nervous System Diseases, Faculty of General Medicine
V. A. Petrukhin
Russian Federation
E. B. Tsevtsevadze
Russian Federation
S. R. Nurmukhametova
Russian Federation
Department of Neurology with Course of Neurosurgery and Medical Genetics
F. Yu. Garifullina
Russian Federation
Department of Neurology with Course of Neurosurgery and Medical Genetics
References
1. Власов П.Н, Карлов В.А, Кушлинский Н.Е. Фармако-гормональные взаимоотношения при применении карбамазепина и вальпроевой кислоты у больных эпилепсией женщин детородного возраста. Журнал неврологии и психиатрии им. С.С. Корсакова. 2001;201(11):26-30 [Vlasov PN, Karlov VA, Kushlinskii NE. Pharmaco-hormonal relationship in the application of carbamazepine and valproic acid in patients with epilepsy, women of childbearing age. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2001;201(11):26-30 (In Russ.)].
2. Карлов ВА. Эпилепсия у детей и взрослых женщин и мужчин: руководство для врачей. Москва: Медицина; 2010. 720 с. [Karlov VA. Epilepsiya u detei i vzroslykh zhenshchin i muzhchin. Rukovodstvo dlya vrachei [Epilepsy in children and adult women and men. Manual for Physicians]. Moscow: Meditsina; 2010. 720 p.].
3. Lofgren E. Reproductive endocrine function in women with epilepsy: The role of epilepsy type and medication. Epilepsy Behav. 2007;10:77. doi: 10.1016/j.yebeh.2006.09.011
4. Isojarvi JI, Laatikainen TJ, Knip M, et al. Obesity and endocrine disorders i women taking valproate for epilepsy. Ann Neurol. 1996;39:579-84. doi: 10.1002/ana.410390506
5. Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia. 2003;44 Suppl 4:11-20. doi: 10.1046/j.1528- 1157.44.s4.2.x
6. Власов ПН, Серова ОФ, Дранко ДВ, Филатова НВ. Гормонально-зависимая патология женской половой сферы при монотерапии вальпроатами, карбамазепином и ламотриджином. Неврология, нейропсихиатрия, психосоматика. 2012;4(1S):34-8 [Vlasov PN, Serova OF, Dranko DV, Filatova NV. Hormone-dependent abnormality of the female sexual sphere during monotherapy with valproate, carbamazepine, and lamotrigine. Nevrologiya, neyropsikhiatriya, psikhosomatika =Neurology, Neuropsychiatry, Psychosomatics. 2012;4(1S):34-8 (In Russ.)]. doi: 10.14412/2074-2711-2012-2496
7. Betts T. A study of anticonvulsant medication on ovarian functoin in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure. 2003;12:323-9. doi: 10.1016/S1059-1311(03)00065-7
8. De Vries L, Karasik A, Landau Z, et al. Endocrine effect of vaiproate in adolescent girls with epilepsy. Epilepsia. 2007;48:470-7. doi: 10.1111/j.1528-1167.2006.00953.x
9. Goldberg SH. Endocrine effects of valproic acid therapy in girls with epilepsy: A procpective study. Eur J Paediatr Neurol. 2014 Nov;18(6):759-65. doi: 10.1016/j.ejpn.2014.07. 004. Epub 2014 Jul 29.
10. Murialdo G. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol. 1998;21:52-8.
11. Краснопольский ВИ. Синдром поликистозных яичников: информационно-методическое письмо. Москва, 2005. 40 с. [Krasnopol'skii V.I. Sindrom polikistoznykh yaichnikov: Informatsionno-metodicheskoe pis'mo [Polycystic ovary syndrome: Information and methodical letter]. Moscow, 2005. 40 p.].
12. The Rotterdam ESHRE/FSRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7. doi: 10.1093/humrep/deh098
Review
For citations:
Anisimova DV, Magzhanov RV, Vlasov PN, Petrukhin VA, Tsevtsevadze EB, Nurmukhametova SR, Garifullina FY. The pattern of female genital hormonal disease in juvenile myoclonic epilepsy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;(1S):24-30. (In Russ.) https://doi.org/10.14412/2074-2711-2016-1S-24-30